PHINC DEVELOPMENT   Report issue

For profit Phase 1
Founded: Evry France (2008)

Organization Overview

First Clinical Trial
2014
NCT02091310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

PHINC DEVELOPMENT

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 5